Nutritional benefits of neonatal screening for cystic fibrosis

New England Journal of Medicine

Volumn 337, Issue 14, 1997, Pages 963-969

  Farrell, Philip M ^a,c   Kosorok, Michael R ^a   Laxova, Anita ^a   Shen, Guanghong ^a   Koscik, Rebecca E ^a   Bruns, W Theodore ^b   Splaingard, Mark ^b   Mischler, Elaine H ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARBOHYDRATE DIET; CHILD NUTRITION; CYSTIC FIBROSIS; DIAGNOSTIC VALUE; DIET SUPPLEMENTATION; DNA DETERMINATION; EARLY DIAGNOSIS; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; NEWBORN; NEWBORN SCREENING; NUTRITIONAL STATUS; PANCREAS INSUFFICIENCY; PRIORITY JOURNAL;

BODY HEIGHT; BODY WEIGHT; CYSTIC FIBROSIS; HUMANS; INFANT; INFANT, NEWBORN; NEONATAL SCREENING; NUTRITION DISORDERS; NUTRITIONAL STATUS; PROSPECTIVE STUDIES; TRYPSINOGEN;

EID: 0030803131     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199710023371403     Document Type: Article

References (38)

1. Patient registry 1995 annual data report. Bethesda, Md.: Cystic Fibrosis Foundation, 1996.
2. Rosenstein BJ, Langbaum TS, Metz SJ. Cystic fibrosis: diagnostic considerations. Johns Hopkins Med J 1982;150:113-20.
3. Blythe S, Farrell PM. Advances in the diagnosis and management of cystic fibrosis. Clin Biochem 1984;17:277-83.
4. Farrell PM, Gilbert-Barness E, Bell J, et al. Progressive malnutrition, severe anemia, hepatic dysfunction, and respiratory failure in a three-month-old white girl. Am J Med Genet 1993;45:725-38.
5. Wilfond BS, Farrell PM, Laxova A, Mischler E. Severe hemolytic anemia associated with vitamin E deficiency in infants with cystic fibrosis. Clin Pediatr 1994;33:2-7.
6. Boat TF, Welsh MJ, Beaudet AL. Cystic fibrosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited disease. 6th ed. Vol. 2. New York: McGraw-Hill, 1989:2649-80.
7. Lai HC, Kosorok MR, Sondel SA, et al. Growth status in children with cystic fibrosis based on the National Cystic Fibrosis Patient Registry data: evaluation of various criteria used to identify malnutrition. J Pediatr (in press).
8. Shwachman H, Redmond A, Khaw K-T. Studies in cystic fibrosis: report of 130 patients diagnosed under 3 months of age over a 20-year period. Pediatrics 1970;46:335-43.
9. Crossley JR, Elliott RB, Smith PA. Dried-blood spot screening for cystic fibrosis in the newborn. Lancet 1979;1:472-4.
10. Hammond KB, Abman SH, Sokol RJ, Accurso FJ. Efficacy of statewide neonatal screening for cystic fibrosis by assay of trypsinogen concentrations. N Engl J Med 1991;325:769-74.
11. Gregg RG, Wilfond BS, Farrell PM, Laxova A, Hassemer D, Mischler EH. Application of DNA analysis in a population-screening program for neonatal diagnosis of cystic fibrosis (CF): comparison of screening protocols. Am J Hum Genet 1993;52:616-26.
12. Ad Hoc Committee Task Force on Neonatal Screening, Cystic Fibrosis Foundation. Neonatal screening for cystic fibrosis: position paper. Pediatrics 1983;72:741-5.
13. Gregg RG, Simantel A, Farrell PM, et al. Newborn screening for cystic fibrosis in Wisconsin: comparison of biochemical and molecular methods. Pediatrics 1997;99:819-24.
14. Farrell PM, Mischler EM. Newborn screening for cystic hbrosis. Adv Pediatr 1992;39:35-70.
15. Tluczek A, Mischler EH, Farrell PM, et al. Parents' knowledge of neonatal screening and response to false positive cystic fibrosis testing. J Dev Behav Pediatr 1992;13:181-6.
16. Fost NC, Farrell PM. A prospective randomized trial of early diagnosis and treatment of cystic fibrosis: a unique ethical dilemma. Clin Res 1989; 37:495-500.
17. Shwachman H, Kulczycki LL. Long-term study of one hundred five patients with cystic fibrosis: studies made over a five-to fourteen-year period. Am J Dis Child 1958;96:6-15.
18. Ramsey BW, Boat TF. Outcome measures for clinical trials in cystic fibrosis: summary of a Cystic Fibrosis Foundation consensus conference. J Pediatr 1994;124:177-92.
19. Hamill PVV, Drizd TA, Johnson CL, Reed RB, Roche AF, Moore WM. Physical growth: National Center for Health Statistics percentiles. Am J Clin Nutr 1979;32:607-29.
20. Marcus MS, Sondel SA, Farrell PM, et al. Nutritional status of infants with cystic fibrosis as related to dietary intake. Am J Clin Nutr 1991;54: 578-85.
21. Farrell PM, Bieri JG, Fratantoni JF, Wood RE, di Sant'Agnese PA. The occurrence and effects of human vitamin E deficiency: a study in patients with cystic fibrosis. J Clin Invest 1977;60:233-41.
22. Durie PR, Forstner GG, Gaskin KJ, et al. Age-related alterations of immunoreactive pancreatic cationic trypsinogen in sera from cystic fibrosis patients with and without pancreatic insufficiency. Pediatr Res 1986;20:209-13.
23. van Egmond AWA, Kosorok MR, Koscik R, Laxova A, Farrell PM. Effect of linoleic acid intake on growth of infants with cystic fibrosis. Am J Clin Nutr 1996;63:746-52.
24. Wei LJ, Su JQ, Lachin JM. Interim analyses with repeated measurements in a sequential clinical trial. Biometrika 1990;77:359-64.
25. Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika 1983;70:659-63.
26. Liang K-Y, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
27. Karim MR, Zeger SL. GEE: a SAS macro for longitudinal data analysis, version 1. Technical report no. 674. Baltimore: Johns Hopkins University Department of Biostatistics, 1988.
28. Fisher LD, van Belle G. Biostatistics: a methodology for the health sciences. New York: John Wiley, 1993.
29. Allen DB, Farrell PM. Newborn screening: principles and practice. Adv Pediatr 1996;43:231-70.
30. Hennekens CH, Buring JE. Epidemiology in medicine. Boston: Little, Brown, 1987.
31. Waters DL, Dorney SFA, Gaskin KJ, Gruca MA, O'Halloran M, Wilcken B. Pancreatic function in infants identified as having cystic fibrosis in a neonatal screening program. N Engl J Med 1990;322:303-8.
32. Kraemer R, Rudeberg A, Hadorn B, Rossi E. Relative underweight in cystic fibrosis and its prognostic value. Acta Paediatr Scand 1978;67:33-7.
33. Corey M, McLaughlin FJ, Williams M, Levison H. A comparison of survival growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol 1988;41:583-91.
34. Foster SW, Farrell PM. Enhancing nutrition in cystic fibrosis with comprehensive therapies. J Pediatr Gastroentcrol Nutr 1996;22:238-9.
35. Ramsey BW, Farrell PM, Pencharz P, Consensus Committee. Nutritional assessment and management in cystic fibrosis: a consensus report. Am J Clin Nutr 1992;55:108-16.
36. Wilcken B. Newborn screening for cystic fibrosis: its evolution and a review of the current situation. Screening 1993;2:43-62.
37. Farrell PM, Aronson RA, Hoffman G, Laessig RH. Newborn screening for cystic fibrosis in Wisconsin: first application of population-based molecular genetics testing. Wis Med J 1994;93:415-21.
38. Newborn screening for cystic fibrosis: a paradigm for public health genetics policy development. MMWR Morb Mortal Wkly Rep (in press).